latest news releases from the newsroom
Unlimited EDGAR Filings Through MacReport.Net Program
MELVILLE, N.Y., Sept. 24, 2003 (PRIMEZONE) -- The MacReport.Net, Inc. (OTCBB:MRPT), an information and media company, announced that it will begin including an unlimited number of SEC EDGAR filings in its hassle-free, month-to-month, client-care program. To date, this offer includes unlimited press releases combined with e-mail direct marketing distribution and a feature-rich audio communications platform complete with transcription services, as well as web hosting, networking and consulting solutions. All aspects of the program are detailed fully in regular monthly client action reports.
Autoliv Receives Chrysler Award
STOCKHOLM, Sweden, Sept. 24, 2003 (PRIMEZONE) -- Autoliv (NYSE:ALV) (Pink Sheets:AUTVF) (LSE:ALllq) -- the worldwide leader in automotive safety systems -- has received the Chrysler Group's Component Award in North America for overall performance excellence in 2002. Autoliv is the only restraint supplier to receive this prestigious award.
Ahold completes sale of operation in Paraguay
ZAANDAM, The Netherlands, Sept. 24, 2003 (PRIMEZONE) -- Ahold (NYSE:AHO) (Other OTC:AHODF) today announced it has successfully completed the sale of its 100% interest in Supermercados Stock S.A. to A.J. Vierci.
Comment by Skandia's board of directors on the independent examination of Skandia Liv
STOCKHOLM, Sweden, Sept. 24, 2003 (PRIMEZONE) -- The Board of Directors of Skandia (Other OTC:SKNFF) (LSE:SDIAq) has reviewed the report submitted by the independent investigative panel commissioned by Skandia Liv's board. Skandia has noted the investigative panel's conclusion that it "did not find any evidence that the Parent Company improperly profited at the expense of Skandia Liv."
Celltech Group plc
Celltech Group PLC Announces Merck Extends Development Period For PDE4 Collaboration With Celltech
SLOUGH, UK, Sept. 24, 2003 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) announces that Merck & Co., Inc. (NYSE:MRK) (Pink Sheets:MCKIF) has exercised its option to extend the Development Period regarding its phosphodiesterase-4 (PDE4) inhibitors collaboration with Celltech. The exercise of this option enables Merck to maintain exclusive access to Celltech's PDE4 intellectual property estate, which was licensed by Celltech to Merck as part of their collaboration in 1994. Pursuant to this, Merck will shortly make an undisclosed milestone payment to Celltech.
Skandia -- Embedded value review
STOCKHOLM, Sweden, Sept. 24, 2003 (PRIMEZONE) -- After the Annual General Meeting in April this year, the Board of Skandia Insurance Company Ltd. (Other OTC:SKNFF)(LSE:SDIAq) commissioned an independent investigation to review Skandia's reporting and disclosure of embedded value. The outcome of this investigation still has to be finalized.
Sex, Fear and Politics on a Southern Campus - Author Spins Tale Involving Shocking University Scandal Within Top Administration
DALLAS, Sept. 23, 2003 (PRIMEZONE) -- Hiding behind a facade of intellectual academia, university professors and administrators conceal a scandalous secret. When Liz Hunter, the wife of an assistant professor, uncovers this secret lifestyle, she is punished quietly. In her new novel, In the Shadow of the Tower: Sex, Fear, and Politics on a Southern Campus (now available through 1stBooks), author Marjorie Hacker tells the suspenseful story of one woman whose family is hurt by a secret she must keep.